Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trialThierry Conroy, Antoine Adenis, S. Gourgou-Bourgade et al.|The Lancet Oncology|2014Cited by 446
Clinical Outcome of the ACCORD 12/0405 PRODIGE 2 Randomized Trial in Rectal CancerJean‐Pierre Gérard, Thierry Conroy, D. Azria et al.|Journal of Clinical Oncology|2012Cited by 431